ForFarmers N.V.: Marloes Roetgerink appointed as member of the Executive Board of ForFarmers N.V.

Press release

Lochem, 28 May 2024

Marloes Roetgerink appointed as member of the Executive Board of ForFarmers N.V.

ForFarmers’ shareholders today resolved to appoint Mrs Marloes Roetgerink as Executive Board member as per 1 June 2024.This resolution was taken during the Extraordinary General Meeting of Shareholders of ForFarmers N.V., which was held today. Marloes Roetgerink will fulfil the position of Chief Financial Officer. The term of her appointment will start as per 1 June 2024 and will end at the annual general meeting in 2028, when she is eligible for reappointment for a term of 4 years.

This press release contains information which qualifies as inside information within the meaning of Article 7, paragraph 1 of the EU Market Abuse Regulation.

Note to the editor / For additional information:
ForFarmers, Floor van Maaren: floor.vanmaaren@forfarmers.eu or +31 (0)573 28 88 00

Company profile
ForFarmers N.V. (‘ForFarmers’) offers complete feed solutions to the (organic) livestock farming industry. With its mission “For the Future of Farming”, ForFarmers is committed to a future-proof farming business and making the agricultural sector more sustainable. Our goal is clear: to contribute to a good return and a robust long-term business model. How? By leading the way with knowledge, advice, support and products on the farm. Close to the farmers, solution-oriented and with an open view of the future. The result: a contribution to affordable and sustainable food, For the Future of Farming.

With sales of approximately 8.4 million tonnes of feed, ForFarmers is a leading player in Europe. The company has production operations in the Netherlands (head office), Germany, Poland and the United Kingdom, and exports to various countries within and outside Europe. ForFarmers has around 2,400 employees and generated revenue of approximately €3 billion in 2023. ForFarmers N.V. is listed on Euronext Amsterdam.

ForFarmers N.V.
P.O. Box 91
7240 AB Lochem
T: +31 (0)573 28 88 00
info@forfarmers.eu, www.forfarmersgroup.eu

FORWARD-LOOKING STATEMENTS
This press release contains forward-looking statements, for example relating to ForFarmers’ legal obligations in terms of capital and liquidity positions in certain specified scenarios. In addition forward-looking statements may, without limitation, contain phrases such as “intends to”, "expects”, “takes into account”, "is aimed at”, ''plans to”, "estimates" and/or words of a similar meaning. These statements pertain to or may affect matters in the future, such as ForFarmers’ future financial results, business plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties which may lead to material differences between the actual results and performance and the expected future results or performance as implicitly or explicitly contained in the forward-looking statements. Factors that may result in, or contribute to, deviations from current expectations include, but are not limited to developments in legislation, technology, taxation, jurisprudence and regulations, share price fluctuations, legal proceedings, investigations by regulatory bodies, the competitive landscape and general economic conditions. These and other factors, risks and uncertainties that may affect any forward-looking statements or the actual results of ForFarmers are discussed in the most recently published annual report. The forward-looking statements in this press release relate solely to statements as of the date of this document and ForFarmers accepts no obligation or responsibility whatsoever to update the forward-looking statements contained in this release, regardless of whether these pertain to new information, future events or otherwise, unless ForFarmers is legally obliged to do so.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.